大或巨大肝癌腹腔镜与开腹肝切除的多中心疗效比较
本研究基于八中心2015-2021年连续病例,倾向性评分匹配后比较腹腔镜与开腹肝切除治疗大(5-10 cm)或巨大(>10 cm)肝癌的围术期与肿瘤学结局。匹配后各369例,腹腔镜组手术时间更短、出血更少、住院更短,总生存与无复发生存无显著差异。
要点
- 大或巨大肝癌行腹腔镜肝切除围术期优于开腹,长期生存相当。
- 多因素Cox显示AFP>400 ng/mL、肿瘤大小、多发病灶及微血管侵犯为独立预后因素。
- 亚组分析显示大肝癌与巨大肝癌中腹腔镜均减少出血并加速康复。
核心结论
- 对选择的大或巨大肝癌患者,腹腔镜肝切除是安全有效的开腹替代方案,围术期更优且长期生存相当。
主要发现
- 共纳入开腹560例、腹腔镜421例,匹配后每组369例。
- 匹配后腹腔镜组手术时间更短、术中出血更少、住院时间更短。
- 两组总生存与无复发生存无显著差异。
- 多因素Cox回归显示AFP>400 ng/mL、肿瘤大小(5-10 cm与>10 cm)、多发病灶及微血管侵犯为总生存与无复发生存的独立预后因素。
- 亚组分析中,大肝癌腹腔镜组出血更少、住院更短;巨大肝癌腹腔镜组出血更少、恢复更快。
临床怎么用
- 对选择的大或巨大肝癌患者,可考虑腹腔镜肝切除以改善围术期结局。
- 术前应评估AFP>400 ng/mL、多发病灶及微血管侵犯等预后因素。
局限性
- 回顾性研究存在选择偏倚,虽经倾向性评分匹配仍不能完全消除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to compare both perioperative and oncological outcomes between laparoscopic liver resection (LLR) and open liver resection (OLR) for patients with large (5-10 cm) or huge (> 10 cm) hepatocellular carcinoma (HCC). METHODS: This study analyzed consecutive patients with large or huge HCC who underwent either LLR or OLR across eight medical centers between January 2015 and December 2021. Clinical data were collected from prospectively maintained databases. To address potential selection bias inherent in retrospective studies, we performed 1:1 propensity score matching (PSM) analysis. RESULTS: We enrolled 560 patients undergoing OLR and 421 patients undergoing LLR based on predefined inclusion criteria. After PSM (369 patients per group), the LLR group demonstrated superior perioperative outcomes compared to the OLR group, including significantly reduced operative duration, decreased intraoperative blood loss, and shorter hospitalization. Long-term oncological outcomes were comparable between approaches, with no significant differences in overall survival (OS) or recurrence-free survival (RFS). Multivariate Cox regression identified several independent prognostic factors for both OS and RFS: serum alpha-fetoprotein > 400 ng/mL, tumor size (both 5-10 cm and > 10 cm), multifocal disease, and microvascular invasion. Subgroup analyses confirmed the advantages of LLR across tumor size categories. For large HCC, LLR patients exhibited significantly less blood loss and shorter hospital stays. Similarly, in huge HCC, the LLR group showed reduced blood loss and faster recovery compared to the OLR group. CONCLUSION: LLR is a safe and effective alternative to OLR for selected patients with large or huge HCC, offering superior perioperative outcomes while maintaining equivalent long-term survival.
引用
- Yang S, Zhang W, Feng J, et al. Outcomes of laparoscopic versus open liver resection in patients with large or huge HCC: a multicenter study. Surg Endosc. 2025. PMID: 41408435. doi:10.1007/s00464-025-12482-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。